Thrivent Financial for Lutherans’s Albany Molecular Research Inc AMRI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-13,460
| Closed | -$292K | – | 2471 |
|
|
2017
Q2 | $292K | Buy |
13,460
+820
| +6% | +$17.8K | ﹤0.01% | 1759 |
|
|
2017
Q1 | $177K | Buy |
12,640
+650
| +5% | +$9.1K | ﹤0.01% | 1841 |
|
|
2016
Q4 | $225K | Buy |
11,990
+550
| +5% | +$10.3K | ﹤0.01% | 1801 |
|
|
2016
Q3 | $189K | Sell |
11,440
-62,480
| -85% | -$1.03M | ﹤0.01% | 1831 |
|
|
2016
Q2 | $993K | Buy |
73,920
+540
| +0.7% | +$7.25K | ﹤0.01% | 1098 |
|
|
2016
Q1 | $1.12M | Sell |
73,380
-38,300
| -34% | -$586K | 0.01% | 1042 |
|
|
2015
Q4 | $2.22M | Buy |
111,680
+100,330
| +884% | +$1.99M | 0.01% | 814 |
|
|
2015
Q3 | $198K | Buy |
+11,350
| New | +$198K | ﹤0.01% | 1625 |
|
|
2014
Q3 | – | Sell |
-46,650
| Closed | -$939K | – | 1907 |
|
|
2014
Q2 | $939K | Buy |
+46,650
| New | +$939K | 0.01% | 892 |
|